Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Article
MedComm
2026
Envonalkib Versus Crizotinib in Treatment-Naive
Jie Huang et al.
PubMed ↗
Full text ↗
Publisher ↗
No numbers read from the abstract.
Not cited yet
The trial
NCT04009317
phase 3
260 enrolled
2019
Envonalkib Versus Crizotinib in Treatment-Naive | OpenQuestion